(Q36738838)

English

Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

scientific article published on January 1968

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy). (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

author name string

Duncan GG

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Elliott FA

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Duncan TG

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Schatanoff J

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 January 1968

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Transactions of the American Clinical and Climatological Association

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

79

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

216-228

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/5760587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Settling of sludge in human patients; a contribution to be biophysics of disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/5760587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements

1 reference

https://pubmed.ncbi.nlm.nih.gov/5760587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE

1 reference

https://pubmed.ncbi.nlm.nih.gov/5760587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE EFFECTS OF ATROMID ON THE METABOLISM OF ADRENAL STEROIDS AND ON PLASMA LIPID FRACTIONS

1 reference

https://pubmed.ncbi.nlm.nih.gov/5760587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A STUDY OF THE EFFECT OF ATROMID THERAPY IN EXUDATIVE DIABETIC RETINOPATHY

1 reference

https://pubmed.ncbi.nlm.nih.gov/5760587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE

1 reference

https://pubmed.ncbi.nlm.nih.gov/5760587

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36738838&oldid=1516216023"